Log In
Print
BCIQ
Print
Print this Print this
 

BMS-791325

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionNon-nucleoside HCV NS5B polymerase inhibitor
Molecular Target HCV NS5B polymerase
Mechanism of ActionViral polymerase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat chronic HCV infection; Treat HCV genotype 1 infection in treatment-naïve patients
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today